Abstract
Introduction
Symptom burden is high in people with chronic kidney disease (CKD) (1, 2) . This negatively affects patients' quality of life, and increases the risk of depression and treatment non-adherence (3) (4) (5) .
Improving symptom management is a research priority for CKD patients (6) , and clinical practice guidelines recommend it as a key element of CKD care (7) (8) (9) . But despite their prevalence, impact and importance, CKD symptoms often remain unrecognised and untreated (10) (11) (12) .
Uraemic pruritus, or itch, is a common, yet often overlooked CKD symptom, with estimated prevalence ranging from 25% (13) to 44% (14) . Whilst the underlying mechanisms that cause itch in people with CKD remain poorly understood (15) , there are several recommended nonpharmacologic and pharmacologic treatments available, such as gentle soaps and moisturisers, topical ointments and Gabapentin (16) (17) (18) . Nonetheless, 20% of severely affected patients in a large cohort study -the Dialysis Outcomes and Practice Patterns Study (DOPPS)-were not treated for itch (12) , mirroring low treatment rates found in other studies (11, 19) . Untreated itch is associated with disturbed sleep, depression, higher resource use and lower general health and quality of life in a dose-response manner (13, 14, (20) (21) (22) .
Healthcare professionals tend to underestimate the prevalence of itch (12, 23, 24) . One explanation may be that patients do not always report itch: 17% of severely affected patients in the DOPPS said they had never discussed their itch with a healthcare professional (12) . However, reasons for underreporting of itch in CKD are unknown. It is also unclear if and how patients' reporting behaviors are influenced by how healthcare professionals view, discuss and manage itch. Therefore, we conducted a qualitative study that combined patient and healthcare professional interviews to better understand why itch is underreported in CKD.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT

Running head: REASONS FOR UNDERREPORTING OF URAEMIC PRURITUS 5
Material and Methods
We used the Consolidated Criteria for Reporting Qualitative Health Research (25) .
Participant selection
Patients were eligible if they (i) were under the care of a nephrologist; (ii) self-reported having been bothered by itch in the last three years; and (iii) understood and spoke English. For the interviews with healthcare professionals, we recruited consultant and trainee nephrologists and renal nurses from three kidney centres in the UK. Local research nurses purposively selected and invited eligible participants, aiming for a maximum variation in age, gender, treatment modality (CKD stage 1-5; dialysis;
transplanted) and itch experience (current; past) (26) .
Data collection
We conducted face-to-face, semi-structured individual interviews with patients and nephrologists; nurses participated in focus group interviews. We developed topic guides using previous studies on barriers to symptom reporting and management (23, 27) ; the Common Sense Model of self-regulation, which is a theoretical model of processes underlying the self-management of symptoms and other health threats in everyday life (28, 29) ; and input from two patient representatives and two nephrologists (HR and JOB). The patient guide included topics such as the impact of itch on everyday life, experiences of reporting itch to health professionals, and reasons for not reporting itch. For healthcare professionals, topics were experiences of patients reporting itch, perceived importance of itch as part of overall kidney care, and approaches to diagnosing and managing itch. All interviews were audio-recorded and transcribed verbatim.
Data analysis
We uploaded transcripts into NVivo (Version 11, QSR International Pty Ltd., 2014) to support data management and analysis. The Framework Method informed a two-stage data analysis strategy (30) .
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First, we developed and finalised a matrix that included both theory-driven codes, as well as those related to emerging themes from the first fifteen interview transcripts. To pilot-test and further refine the matrix, two researchers (GA and SvdV) independently coded five patient and three healthcare professional interviews, and resolved discrepancies through discussion. For all codes, the inter-rater agreement between coders was above 80% and Cohen's κ ≥ .40 (31) . Second, we used the final matrix to code the remaining transcripts. We reached data saturation after analysing the 21 st and 11 th patient and healthcare professional transcript, respectively. Codes were described conceptually and discussed by the research team to identify iteratively cross-cutting themes between patient and healthcare professional interviews (i.e. participants' triangulation). Once we agreed on themes and subthemes, input from two patient representatives aided the interpretation of findings and ensured themes reflected the patients' perspective (i.e. member checking).
Ethical approval
The study was approved by the UK Health Research Authority's Research Ethics Service, East
Midlands -Leicester South Research Ethics Committee (IRAS ID 220320).
Results
Of the 41 patients approached, 25 (61%) agreed to be interviewed. Reasons for declining participation were: unable to schedule the interview (N = 10); loss of interest in the study (N = 4); health-related reasons (N = 2). Ten nephrologists and twelve renal nurses took part in the healthcare professional interviews. [Insert Table 1 here] M A N U S C R I P T
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attitudes towards the importance of itch as a health issue (patients' attitudes; healthcare professionals' attitudes); and prompts for itch assessment during consultations (routine practice; itch as a marker; itch severity). Table 2 and supplemental Table S1 contain illustrative quotations.
[Insert Table 2 here]
Knowledge on causes and treatment of itch
Lack of awareness of the relationship between itch and CKD Several patients reported they had long been unaware that itch might be a symptom of their kidney disease, partly because the kidney team had not mentioned itch as a CKD symptom. Instead, patients attributed it to other conditions, such as dry skin. Accordingly, they sought help from non-kidney healthcare professionals, such as general practitioners (GPs) or dermatologists;
nephrologists' accounts confirmed this by suggesting that many patients had already discussed itch with their GP before bringing it up in a consultation with their kidney team. However, non-kidney healthcare professionals often seemed similarly unaware of the relation between itch and kidney disease, potentially resulting in ineffective treatment (e.g., treating it as a mere skin condition). M A N U S C R I P T
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"[The nurse] sort of advised me: 'well, when your kidney functions go down you get problems like that'. I think it was like an acceptance these things happen, and just let me know that, you know, that's what to expect." (PLi12, male, 55, dialysis)
Other reasons for this accepting attitude included seeing itch as something trivial, a history of unsuccessful treatments, or fear of being prescribed additional medications.
Healthcare professionals' attitudes Also healthcare professionals described how they dismissed the importance of itch in favor of other symptoms and health issues. They acknowledged that their attitudes towards itch or symptoms in general might have influenced whether or not patients brought it up during the consultation. Some argued that patients may censor themselves because they anticipate that their nephrologist finds other issues more important; does not consider itch worth discussing; or will not take them seriously. 
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
Prompts for itch assessment during consultations
Routine practice
From both patients' and healthcare professionals' accounts, it was apparent that symptom assessment practices varied widely between healthcare providers. Whereas many patients said they had to raise the issue themselves, others were routinely asked at clinic visits. And despite most renal nurses and nephrologists being aware of itch remaining unreported, many expected patients to bring it up, with only a few saying they would systematically ask about it. Healthcare professionals who thought itch was caused by high serum phosphate levels discussed the symptom as part of a strategy to motivate patients to better manage their phosphate.
"I've got the script I've got to get to the end of and I hope I give the patients enough time to get to […] at least a fair amount of whatever their script is. […] I don't bring that up as a specific
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Itch severity
Patients and healthcare professionals suggested that itch might only be discussed after reaching a certain level of severity; for example, when resulting in sleep deprivation or skin damage.
"If it stops me sleeping, I would tell them" (PLi01, male, 80 years, dialysis)
Furthermore, patients indicated that itch severity fluctuated over time. And since periods of severe itching did not always coincide with seeing the nephrologist, patients would seek help from other healthcare professionals, such as their GP or renal nurses. Additionally, healthcare professionals suggested that patients may not recall being itchy when visiting the renal unit if the symptom was not bothering them at the time. consultation. Related to the latter, our study additionally found that patients also expected healthcare professionals to ask about symptoms, and that they assumed the absence of a clinician's prompt to imply that symptoms did not warrant discussion.
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Running head: REASONS FOR UNDERREPORTING OF URAEMIC PRURITUS 13 Inclusion of nephrologists and non-dialysis CKD patients in our sample may explain why some of the reasons in our 'prompts for itch assessment' theme were not identified by Flythe et al. For example, we found that itch might remain undiscussed if it is not severe at the time of the clinic encounter. This is more likely in people who have an outpatient visit every three months, compared to those who come to the dialysis unit three times a week. We also identified variation in whether and how symptoms were assessed, which may indicate that the role of symptoms in disease management differs between stages of CKD severity and types of healthcare professionals.
Relation to theory
We used the Common Sense Model (CSM) of self-regulation as the theoretical framework to guide data collection and analysis. It poses that people's beliefs about their illness (i.e. illness representations) enables them to make sense of symptoms, and that this affects coping strategies, which in turn impacts on health outcomes (28, 29) . Not reporting symptoms may reflect a negative or passive-avoidant coping strategy. Therefore, to support patients adopt more positive coping strategies to improve their symptom burden, quality of life and other outcomes, we should address reasons for underreporting that are related to people's illness representations.
One reason for underreporting identified in our study was patients' lack of knowledge on the relation between CKD and itch. This links to CSM's cause component which refers to people's individualistic ideas about the perceived cause of a condition. CSM proposes that enhancing this knowledge would improve ability to self-regulate, and thus the likelihood that people will engage in self-reporting as part of an active coping approach (28) . The latter may also be achieved through strengthening patients'
beliefs that itch could be controlled (CSM's controllability component), for example, through an intervention that prompts healthcare professionals to ask about itch and suggests recommended treatments. This would avoid the impression that itch is untreatable and thus not worth discussing.
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Implications for clinical practice
We suggest three ways to improve reporting and management of itch, and also of CKD symptoms more generally.
Include information on symptoms in pre-dialysis education
Whereas symptoms are often mentioned in patient information on CKD (33,34), they may be absent in materials that inform people on dialysis and other forms of kidney replacement therapy (KRT) (35) .
Since KRT does not always relieve itch and other symptoms, this absence of information negatively affects patients' awareness that some symptoms may be related to CKD and its treatment. Including symptom information as part of pre-KRT education may enhance this understanding (23, 33, 36) and thereby the likelihood that people will discuss their symptoms with others.
Develop clinical practice guidelines on itch management
Not knowing how to treat itch led healthcare professionals in our study to report avoiding discussing it in consultations. Some tried to manage itch by lowering phosphate levels, but no randomised controlled trials have been conducted to evaluate the effectiveness of this strategy, nor have large observational studies confirmed an association between elevated phosphate levels and itch (12) .
However, there is sufficient evidence available on other treatments to warrant development of clinical practice guidelines on itch management (16, 33) . If successfully developed and implemented (37), such guidelines would likely improve knowledge among healthcare professionals of evidence-based treatment options.
Incorporate systematic symptom assessments into kidney routine care
We found that clinical practice of itch assessment varied widely. Incorporating systematic symptom assessments into care would reduce this variation and prompt shared decisions between patients and professionals about symptom management. Routine symptom assessments have been advocated by many others (23, 32, 33, (38) (39) (40) (41) based on evidence that it enhances identification of problems and M A N U S C R I P T 
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Strengths and limitations
To our knowledge, this is the first in-depth qualitative study to investigate reasons for underreporting of itch among people with CKD across stages and treatment modalities. Interviewing both patients and healthcare professionals, and triangulating perspectives between them, increased our understanding of the complexity of the symptom reporting process, such as reciprocal expectations for the other party to raise itch as an issue. This enabled us to provide clear pointers for how to facilitate the reporting process and improve management of itch and potentially other symptoms.
A limitation of our study is that our participants were predominantly white British and all able to speak English, which hampered investigating cultural and language barriers as a reason for underreporting.
In addition, we might not have captured the full range of experiences with regard to itch reporting:
patients and healthcare professionals in our study were likely to be aware of itch as a symptom of CKD and to perceive it as a topic that is worth discussing. Although we do not anticipate that recruiting participants with a wider range of experiences and perspectives would have resulted in different M A N U S C R I P T
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Conclusion
Underreporting of itch is related to patients' lack of awareness of its link with kidney disease, and to their acceptance of itch as something they have to live with. Furthermore, the length and timing of consultations may lead them to prioritise other health issues. Healthcare professionals' assessment and management strategies vary widely and are not necessarily evidence-based. Better patient information, development of clinical practice guidelines, and incorporating systematic symptom assessments into care may improve itch reporting and management in people with CKD.
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Reasons for the underreporting of uremic pruritus in people with chronic kidney disease (Aresi et al) 
